NEW YORK, Feb. 13, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Pacira BioSciences, Inc. (NASDAQ: PCRX). Shareholders who purchased shares of PCRX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff…
Month: February 2025
NEW YORK, Feb. 13, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of BioAge Labs, Inc. (NASDAQ: BIOA). Shareholders who purchased shares of BIOA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff…
NEW YORK, Feb. 13, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of FTAI Aviation Ltd. (NASDAQ: FTAI). Shareholders who purchased shares of FTAI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff…
NEW YORK, Feb. 13, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Cardlytics, Inc. (NASDAQ: CDLX). Shareholders who purchased shares of CDLX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff…
LOS ANGELES, Feb. 13, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Arconic Corporation (“Arconic” or “the Company”) (ARNC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of…
LOS ANGELES, Feb. 13, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Elastic N.V. (“Elastic” or “the Company”) (NYSE: ESTC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of…
GUANGZHOU, China, Feb. 13, 2025 /PRNewswire/ — As China’s No.1 platform for international trade, the 137th Canton Fair has successfully hosted a Southeast Asia roadshow with trade promotion events in Vietnam, Laos and Cambodia in January. “The 137th Canton Fair will further optimize…
LOS ANGELES, Feb. 13, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GSK plc (“GSK” or “the Company”) (NYSE: GSK) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and…
BEIJING, Feb. 13, 2025 /PRNewswire/ — Gaotu Techedu Inc. (“Gaotu” or the “Company”) (NYSE: GOTU), a technology-driven education company and online large-class tutoring service provider in China, today announced that it will report its financial results for the fourth quarter and fiscal…
XPOVIO® is the first XPO1 inhibitor approved in Taiwan for the treatment of adult patients with relapsed/refractory multiple myeloma (R/R MM). After the mainland of China, South Korea, Australia and Singapore, Taiwan market is the fifth APAC market in which XPOVIO® has been approved for…